Gland Pharma Ltd

GLAND

Company Profile

  • Business description

    Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, and Daptomycin Injection, among others. The group is also involved in a vast range of therapeutic categories, including Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarials, Cardiology, and more, to Hormones and related Drugs, Fertility Supplements, and GnRH Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA, and the rest from Europe, India, Canada, Australia, and other regions.

  • Contact

    TSIIC, Phase - IV
    Plot No. 11 and 84
    Pashamylaram (V), Patancheru M
    Sangareddy District
    HyderabadTG502307
    IND

    T: +91 8455699999

    https://www.glandpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2027

    Employees

    4,351

Stocks News & Analysis

stocks

ASX retail share expected to recover despite choppy conditions

Weakening consumer demand a temporary headwind for ASX retailer.
stocks

After earnings, is Microsoft a buy, a sell, or fairly valued?

With third-quarter results surpassing even high-end expectations, here’s what we think of Microsoft stock.
stocks

Albemarle earnings: Shares rally on strong profit growth well above consensus estimates

Albemarle should see sequential profit growth in the second quarter and maintain higher profits through the year.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,980.5031.60-0.35%
CAC 408,112.5789.51-1.09%
DAX 4024,338.63324.98-1.32%
Dow JONES (US)49,609.1612.190.02%
FTSE 10010,233.0743.88-0.43%
HKSE26,393.71232.57-0.87%
NASDAQ26,247.08440.881.71%
Nikkei 22562,713.65120.19-0.19%
NZX 50 Index13,133.3941.74-0.32%
S&P 5007,398.9361.820.84%
S&P/ASX 2008,744.4036.40-0.41%
SSE Composite Index4,179.950.14-0.00%

Market Movers